Protalix BioTherapeutics, Inc. (PLX) Gross profit 2016–2025
Protalix BioTherapeutics, Inc. (PLX) annual gross profit history from SEC filings — each fiscal year as reported.
$25.8MFY2025 · since FY2016: $801,000 → $25.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $25.8M | -11.4% |
| FY2024 | $29.1M | -31.6% |
| FY2023 | $42.5M | +51.6% |
| FY2022 | $28.0M | +27.5% |
| FY2021 | $22.0M | -57.7% |
| FY2020 | $52.0M | +18.8% |
| FY2019 | $43.8M | +75.6% |
| FY2018 | $24.9M | +521.7% |
| FY2017 | $4.0M | +400.7% |
| FY2016 | $801,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice